2009
DOI: 10.1016/j.lungcan.2009.01.007
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
78
0
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 97 publications
(84 citation statements)
references
References 49 publications
5
78
0
1
Order By: Relevance
“…Overexpression of SHH, GLI1, GLI2, and SMO has also been reported in tumor tissues of 80 patients with non-small cell lung carcinoma. In this series, elevated expression level of SMO correlated with the presence of nodal disease, implicating its role in metastasis and disease progression [42]. Autocrine activation of the Hh pathway has also been shown in breast cancer, both in cell lines and tumoral tissue studies [43][44][45].…”
Section: Autocrine Stimulationmentioning
confidence: 52%
“…Overexpression of SHH, GLI1, GLI2, and SMO has also been reported in tumor tissues of 80 patients with non-small cell lung carcinoma. In this series, elevated expression level of SMO correlated with the presence of nodal disease, implicating its role in metastasis and disease progression [42]. Autocrine activation of the Hh pathway has also been shown in breast cancer, both in cell lines and tumoral tissue studies [43][44][45].…”
Section: Autocrine Stimulationmentioning
confidence: 52%
“…Thus, FOXM1 may be the target of GLI1 in basal cell carcinomas. In addition, FOXM1 overexpression in non-small cell lung carcinoma has been demonstrated to correlate with PTCH1, SMO and GLI1 expression (48). In present study, the association between FOXM1 and Hh signaling molecules was analyzed, and the results indicated that FOXM1 expression significantly correlated with GLI1 (R=0.405, P<0.001), SHh (R=0.416, P<0.001) and PTCH1 (R=0.281, P=0.012) expression.…”
Section: A B C D E F G Hmentioning
confidence: 57%
“…As a typical cell-cycle-related transcription factor, one of the key roles of FoxM1 in carcinogenesis is to promote tumor proliferation (9). In addition, upregulation of FoxM1 is a frequent event in different tumor types, and FoxM1 deficiency triggers reduced cellular proliferation or even growth arrest (10)(11)(12)(13)(14), which suggests that FoxM1 may play an important role in tumorigenesis and progression. Our results revealed that overexpression of FoxM1 occurred from gastritis to gastric cancer progression and H. pylori-induced FoxM1 expression in vivo and in vitro, so FoxM1 might take part in the early stage of gastric cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Aberrant expression of FoxM1 is involved in several tumor types, including hepatocellular carcinoma, basal cell carcinoma, breast cancer, lung cancer, prostate cancer, glioblastomas, and gastric cancer (10)(11)(12)(13)(14)(15)(16)(17)(18), which implies an oncogene role in carcinogenesis. We previously reported that FoxM1 is upregulated in gastric cancer, and its inhibition leads to cellular senescence (18), but the relevance of H. pylori infection and FoxM1 expression associated with the pathogenesis of gastric cancer remains undefined.…”
Section: Introductionmentioning
confidence: 99%